SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?


To: Pierre Aydin who wrote (593)12/17/1997 6:33:00 AM
From: Christopher White  Read Replies (1) | Respond to of 2068
 
Pierre,

In the most recent 'Investor's Intelligence' newsletter, OXHP makes a list of depressed stocks with year end bounce potential. Other stocks on list include ASND, COL, IFMX, NKE, SEG and S among others. "All of these companies have problems of one kind or another, but these problems are already factored into the stock price. There is no guarantee that they will rebound of course, but in these times of very high valuations, we would rather look for stocks among theose that may be overly depressed than those that may be overly hyped."

Christopher



To: Pierre Aydin who wrote (593)12/17/1997 6:52:00 AM
From: Christopher White  Read Replies (1) | Respond to of 2068
 
In the 17 December issue of 'The Outlook,' S&P still has OXHP in their Platinum Portfolio - OXHP a ranking of five, four stars, quality rank of B, and a fair value of $56.80/share.

Christopher